A deep learning pathomic signature predicts survival and recurrence in pancreatic ductal adenocarcinoma independent of CA19-9
- 24 March 2026
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 657, 218452
Abstract
No abstract availableKeywords
Funding Information
- Peking University First Hospital (2023IR23)
- Peking University First Hospital (2024IR11)
- National Key Research and Development Program of China (2021YFA0909900)
- National Key Research and Development Program of China (2023YFC2413400)
- Michigan Medicine-PKUHSC Joint Institute for Translational and Clinical Research (BMU2025JI002)
- Fundamental Research Funds for the Central Universities
- National Health Commission of the People's Republic of China
- National Natural Science Foundation of China (82171722)
- National Natural Science Foundation of China (82271764)
- National Natural Science Foundation of China (82471772)
- Peking University (2024YXXLHGG008)
- Natural Science Foundation of Beijing Municipality (L246015)
This publication has 61 references indexed in Scilit:
- End-to-end prognostication in pancreatic cancer by multimodal deep learning: a retrospective, multicenter studyEuropean Radiology, 2025
- Overcoming therapy resistance in pancreatic cancer: New insights and future directionsBiochemical Pharmacology, 2024
- Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene setCancer Letters, 2024
- Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon CancerJAMA Surgery, 2024
- Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapyCancer Letters, 2023
- The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinomaDiscover Oncology, 2023
- Pancreatic CancerJAMA, 2021
- Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinomaCancer Communications, 2021
- Challenges and Opportunities for Pancreatic Cancer ImmunotherapyCancer Cell, 2020
- Computer‐assisted cytologic diagnosis in pancreatic FNA: An application of neural networks to image analysisCancer Cytopathology, 2017